ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Musculoskeletal Disorders Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-0L14223
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Musculoskeletal Disorders Therapeutics Market Insights Forecast to 2029
BUY CHAPTERS

Global Musculoskeletal Disorders Therapeutics Market Research Report 2025

Code: QYRE-Auto-0L14223
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Johnson & Johnson
Amgen Inc
Pfizer Inc
F.Hoffmann-La Roche
Eli Lilly
Merck
Novartis
Astrazeneca plc
Astellas
AB Sciences
3SBio Inc
Samsung Bioepis
Sanofi
Taisho Pharmaceutical
Takeda
Zosano Pharma
LG Life Sciences
Johnson & Johnson

Musculoskeletal Disorders Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Musculoskeletal Disorders Therapeutics Market

Musculoskeletal Disorders Therapeutics Market

The global market for Musculoskeletal Disorders Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Musculoskeletal Disorders Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Musculoskeletal Disorders Therapeutics.
The Musculoskeletal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Musculoskeletal Disorders Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Musculoskeletal Disorders Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Musculoskeletal Disorders Therapeutics Market Report

Report Metric Details
Report Name Musculoskeletal Disorders Therapeutics Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, Eli Lilly, Merck, Novartis, AstraZeneca, Astellas, AB Sciences, 3SBio, Samsung Bioepis, Sanofi, Taisho Pharmaceutical, Takeda, Zosano Pharma, LG Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Musculoskeletal Disorders Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Musculoskeletal Disorders Therapeutics Market report?

Ans: The main players in the Musculoskeletal Disorders Therapeutics Market are AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, Eli Lilly, Merck, Novartis, AstraZeneca, Astellas, AB Sciences, 3SBio, Samsung Bioepis, Sanofi, Taisho Pharmaceutical, Takeda, Zosano Pharma, LG Life Sciences

What are the Application segmentation covered in the Musculoskeletal Disorders Therapeutics Market report?

Ans: The Applications covered in the Musculoskeletal Disorders Therapeutics Market report are Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia

What are the Type segmentation covered in the Musculoskeletal Disorders Therapeutics Market report?

Ans: The Types covered in the Musculoskeletal Disorders Therapeutics Market report are Biologics, Small Molecules

Recommended Reports

Musculoskeletal Therapies

Arthritis And Pain

Muscular Dystrophy Care

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Biologics
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global Musculoskeletal Disorders Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Osteoarthritis
1.3.3 Osteoporosis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Musculoskeletal Disorders Therapeutics Market Perspective (2020-2031)
2.2 Global Musculoskeletal Disorders Therapeutics Growth Trends by Region
2.2.1 Global Musculoskeletal Disorders Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Musculoskeletal Disorders Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Musculoskeletal Disorders Therapeutics Market Dynamics
2.3.1 Musculoskeletal Disorders Therapeutics Industry Trends
2.3.2 Musculoskeletal Disorders Therapeutics Market Drivers
2.3.3 Musculoskeletal Disorders Therapeutics Market Challenges
2.3.4 Musculoskeletal Disorders Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue
3.1.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Musculoskeletal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Musculoskeletal Disorders Therapeutics Revenue
3.4 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Disorders Therapeutics Revenue in 2024
3.5 Global Key Players of Musculoskeletal Disorders Therapeutics Head office and Area Served
3.6 Global Key Players of Musculoskeletal Disorders Therapeutics, Product and Application
3.7 Global Key Players of Musculoskeletal Disorders Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Musculoskeletal Disorders Therapeutics Breakdown Data by Type
4.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2026-2031)
5 Musculoskeletal Disorders Therapeutics Breakdown Data by Application
5.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Musculoskeletal Disorders Therapeutics Market Size (2020-2031)
6.2 North America Musculoskeletal Disorders Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2020-2025)
6.4 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2020-2031)
7.2 Europe Musculoskeletal Disorders Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2020-2025)
7.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Musculoskeletal Disorders Therapeutics Market Size (2020-2031)
9.2 Latin America Musculoskeletal Disorders Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Musculoskeletal Disorders Therapeutics Introduction
11.1.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Musculoskeletal Disorders Therapeutics Introduction
11.3.4 Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.3.5 Amgen Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Musculoskeletal Disorders Therapeutics Introduction
11.4.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Musculoskeletal Disorders Therapeutics Introduction
11.7.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Musculoskeletal Disorders Therapeutics Introduction
11.8.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.8.5 Novartis Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Introduction
11.9.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.9.5 AstraZeneca Recent Development
11.10 Astellas
11.10.1 Astellas Company Details
11.10.2 Astellas Business Overview
11.10.3 Astellas Musculoskeletal Disorders Therapeutics Introduction
11.10.4 Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.10.5 Astellas Recent Development
11.11 AB Sciences
11.11.1 AB Sciences Company Details
11.11.2 AB Sciences Business Overview
11.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Introduction
11.11.4 AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.11.5 AB Sciences Recent Development
11.12 3SBio
11.12.1 3SBio Company Details
11.12.2 3SBio Business Overview
11.12.3 3SBio Musculoskeletal Disorders Therapeutics Introduction
11.12.4 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.12.5 3SBio Recent Development
11.13 Samsung Bioepis
11.13.1 Samsung Bioepis Company Details
11.13.2 Samsung Bioepis Business Overview
11.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Introduction
11.13.4 Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.13.5 Samsung Bioepis Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Musculoskeletal Disorders Therapeutics Introduction
11.14.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.14.5 Sanofi Recent Development
11.15 Taisho Pharmaceutical
11.15.1 Taisho Pharmaceutical Company Details
11.15.2 Taisho Pharmaceutical Business Overview
11.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Introduction
11.15.4 Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.15.5 Taisho Pharmaceutical Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Musculoskeletal Disorders Therapeutics Introduction
11.16.4 Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.16.5 Takeda Recent Development
11.17 Zosano Pharma
11.17.1 Zosano Pharma Company Details
11.17.2 Zosano Pharma Business Overview
11.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Introduction
11.17.4 Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.17.5 Zosano Pharma Recent Development
11.18 LG Life Sciences
11.18.1 LG Life Sciences Company Details
11.18.2 LG Life Sciences Business Overview
11.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Introduction
11.18.4 LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025)
11.18.5 LG Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
AbbVie
Johnson & Johnson
Amgen Inc
Pfizer Inc
F.Hoffmann-La Roche
Eli Lilly
Merck
Novartis
Astrazeneca plc
Astellas
AB Sciences
3SBio Inc
Samsung Bioepis
Sanofi
Taisho Pharmaceutical
Takeda
Zosano Pharma
LG Life Sciences
Johnson & Johnson
List of Tables
 Table 1. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Biologics
 Table 3. Key Players of Small Molecules
 Table 4. Global Musculoskeletal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Musculoskeletal Disorders Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Musculoskeletal Disorders Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2020-2025)
 Table 8. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2026-2031)
 Table 10. Musculoskeletal Disorders Therapeutics Market Trends
 Table 11. Musculoskeletal Disorders Therapeutics Market Drivers
 Table 12. Musculoskeletal Disorders Therapeutics Market Challenges
 Table 13. Musculoskeletal Disorders Therapeutics Market Restraints
 Table 14. Global Musculoskeletal Disorders Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Musculoskeletal Disorders Therapeutics Market Share by Players (2020-2025)
 Table 16. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2024)
 Table 17. Ranking of Global Top Musculoskeletal Disorders Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Musculoskeletal Disorders Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Musculoskeletal Disorders Therapeutics, Headquarters and Area Served
 Table 20. Global Key Players of Musculoskeletal Disorders Therapeutics, Product and Application
 Table 21. Global Key Players of Musculoskeletal Disorders Therapeutics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Musculoskeletal Disorders Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2020-2025)
 Table 25. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2026-2031)
 Table 27. Global Musculoskeletal Disorders Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application (2020-2025)
 Table 29. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application (2026-2031)
 Table 31. North America Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AbbVie Company Details
 Table 47. AbbVie Business Overview
 Table 48. AbbVie Musculoskeletal Disorders Therapeutics Product
 Table 49. AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 50. AbbVie Recent Development
 Table 51. Johnson & Johnson Company Details
 Table 52. Johnson & Johnson Business Overview
 Table 53. Johnson & Johnson Musculoskeletal Disorders Therapeutics Product
 Table 54. Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 55. Johnson & Johnson Recent Development
 Table 56. Amgen Company Details
 Table 57. Amgen Business Overview
 Table 58. Amgen Musculoskeletal Disorders Therapeutics Product
 Table 59. Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 60. Amgen Recent Development
 Table 61. Pfizer Company Details
 Table 62. Pfizer Business Overview
 Table 63. Pfizer Musculoskeletal Disorders Therapeutics Product
 Table 64. Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 65. Pfizer Recent Development
 Table 66. F. Hoffmann-La Roche Company Details
 Table 67. F. Hoffmann-La Roche Business Overview
 Table 68. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product
 Table 69. F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 70. F. Hoffmann-La Roche Recent Development
 Table 71. Eli Lilly Company Details
 Table 72. Eli Lilly Business Overview
 Table 73. Eli Lilly Musculoskeletal Disorders Therapeutics Product
 Table 74. Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 75. Eli Lilly Recent Development
 Table 76. Merck Company Details
 Table 77. Merck Business Overview
 Table 78. Merck Musculoskeletal Disorders Therapeutics Product
 Table 79. Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 80. Merck Recent Development
 Table 81. Novartis Company Details
 Table 82. Novartis Business Overview
 Table 83. Novartis Musculoskeletal Disorders Therapeutics Product
 Table 84. Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 85. Novartis Recent Development
 Table 86. AstraZeneca Company Details
 Table 87. AstraZeneca Business Overview
 Table 88. AstraZeneca Musculoskeletal Disorders Therapeutics Product
 Table 89. AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 90. AstraZeneca Recent Development
 Table 91. Astellas Company Details
 Table 92. Astellas Business Overview
 Table 93. Astellas Musculoskeletal Disorders Therapeutics Product
 Table 94. Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 95. Astellas Recent Development
 Table 96. AB Sciences Company Details
 Table 97. AB Sciences Business Overview
 Table 98. AB Sciences Musculoskeletal Disorders Therapeutics Product
 Table 99. AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 100. AB Sciences Recent Development
 Table 101. 3SBio Company Details
 Table 102. 3SBio Business Overview
 Table 103. 3SBio Musculoskeletal Disorders Therapeutics Product
 Table 104. 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 105. 3SBio Recent Development
 Table 106. Samsung Bioepis Company Details
 Table 107. Samsung Bioepis Business Overview
 Table 108. Samsung Bioepis Musculoskeletal Disorders Therapeutics Product
 Table 109. Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 110. Samsung Bioepis Recent Development
 Table 111. Sanofi Company Details
 Table 112. Sanofi Business Overview
 Table 113. Sanofi Musculoskeletal Disorders Therapeutics Product
 Table 114. Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 115. Sanofi Recent Development
 Table 116. Taisho Pharmaceutical Company Details
 Table 117. Taisho Pharmaceutical Business Overview
 Table 118. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product
 Table 119. Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 120. Taisho Pharmaceutical Recent Development
 Table 121. Takeda Company Details
 Table 122. Takeda Business Overview
 Table 123. Takeda Musculoskeletal Disorders Therapeutics Product
 Table 124. Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 125. Takeda Recent Development
 Table 126. Zosano Pharma Company Details
 Table 127. Zosano Pharma Business Overview
 Table 128. Zosano Pharma Musculoskeletal Disorders Therapeutics Product
 Table 129. Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 130. Zosano Pharma Recent Development
 Table 131. LG Life Sciences Company Details
 Table 132. LG Life Sciences Business Overview
 Table 133. LG Life Sciences Musculoskeletal Disorders Therapeutics Product
 Table 134. LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2020-2025) & (US$ Million)
 Table 135. LG Life Sciences Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Musculoskeletal Disorders Therapeutics Picture
 Figure 2. Global Musculoskeletal Disorders Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Musculoskeletal Disorders Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Biologics Features
 Figure 5. Small Molecules Features
 Figure 6. Global Musculoskeletal Disorders Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2024 VS 2031
 Figure 8. Osteoarthritis Case Studies
 Figure 9. Osteoporosis Case Studies
 Figure 10. Psoriatic Arthritis Case Studies
 Figure 11. Ankylosing Spondylitis Case Studies
 Figure 12. Fibromyalgia Case Studies
 Figure 13. Musculoskeletal Disorders Therapeutics Report Years Considered
 Figure 14. Global Musculoskeletal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Musculoskeletal Disorders Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Musculoskeletal Disorders Therapeutics Market Share by Region: 2024 VS 2031
 Figure 17. Global Musculoskeletal Disorders Therapeutics Market Share by Players in 2024
 Figure 18. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Musculoskeletal Disorders Therapeutics Revenue in 2024
 Figure 20. North America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Musculoskeletal Disorders Therapeutics Market Share by Country (2020-2031)
 Figure 22. United States Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Musculoskeletal Disorders Therapeutics Market Share by Country (2020-2031)
 Figure 26. Germany Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Region (2020-2031)
 Figure 34. China Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Musculoskeletal Disorders Therapeutics Market Share by Country (2020-2031)
 Figure 42. Mexico Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Country (2020-2031)
 Figure 46. Turkey Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. AbbVie Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 50. Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 51. Amgen Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 52. Pfizer Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 54. Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 55. Merck Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 57. AstraZeneca Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 58. Astellas Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 59. AB Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 60. 3SBio Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 61. Samsung Bioepis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 62. Sanofi Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 63. Taisho Pharmaceutical Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 64. Takeda Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 65. Zosano Pharma Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 66. LG Life Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Musculoskeletal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Spine Disorders Treatment Market Research Report 2024
Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Back and Spine Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neck Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chondroprotective Agent Market Research Report 2025
Global Tendonitis Treatment Drug Market Research Report 2025
Rheumatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Diseases Treatment Market Research Report 2024
Global Orthopedic Cell Therapy Market Research Report 2024
Global Still s Disease Treatment Market Research Report 2025
Global Osteomyelitis Treatment Market Research Report 2025
Global Combination Therapy Drug Market Research Report 2025
Global Intramuscular Drug Delivery Market
Global Axial Spondyloarthritis Treatment Market Research Report 2024
Chronic Low Back Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions